PRESS RELEASE
News
-
UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
-
Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
-
Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
-
Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
-
LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories
-
HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
-
EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
-
Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
-
Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
-
Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
-
PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
-
Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
-
Disclosure of transactions in own shares from May 18 to May 22, 2026
-
Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
-
Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026